Anbioton has been acquired by Elfa Medicamentos
The shareholders of Anbioton have sold the company to Elfa Medicamentos, a Patria Investimentos portfolio company.
Anbioton is focused on the Brazilian pharmaceutical distribution market. The company serves close to 1,400 private hospitals and 200 public entities through partnership agreements with more than 75 pharmaceutical companies.
Elfa Medicamentos was founded in 1989 by Edalmo Leite Fernandes Assis. The company’s operations are focused on the distribution of specialty medicines and generic and branded drugs, hospital supplies, and high value-added solutions for medical plans, clinics, hospitals, government, doctors and patients across the country.
One of Oaklins’ teams in Brazil acted as the exclusive sell-side advisor for Anbioton and its shareholders.
Talk to the deal team
Related deals
Main Capital Partners has acquired a majority stake in CarWise and AutoDisk
CarWise and AutoDisk (together “CarWise”), leading providers of integrated front-, mid- and back-office ERP software for the leasing and car rental sector in the Benelux, have sold a majority stake to Main Capital Partners (“Main”), a prominent European software investor.
Learn moreRAM Infotechnology has acquired Interoperability Group with support from Keensight Capital
RAM Infotechnology (RAM-IT) has acquired Interoperability Group, a leading Dutch provider of healthcare IT solutions, with the support of Keensight Capital, a leading European growth buy-out investor specializing in technology and healthcare.
Learn moreTages Capital SGR has acquired two RTB biomethane plants from Finpower Project
Tages Capital SGR, through its fund Tages Helios Net Zero, has acquired a portfolio consisting of two ready-to-build (RTB) biomethane plants located in Southern Italy.
Learn more